Skip to nav Skip to content

Terminology Specific to Hematology

340B: The 340B Drug Pricing Program enables eligible health care organizations to purchase drugs from manufacturers at reduced prices. It allows eligible health care organizations, such as children’s hospitals, to act as a specialty pharmacy.

Americans with Disabilities Act (ADA): Prohibits discrimination against individuals with disabilities. It ensures equal opportunity in employment, state and local government services, public accommodations, transportation, and telecommunications.

Antifibrinolytics: A class of medications that prevent blood clots from breaking down by inhibiting fibrinolysis.

ATHN: American Thrombosis and Hemostasis Network

COBRA (Consolidated Omnibus Budget Reconciliation Act): A federal law that may allow you to temporarily keep health coverage if your employment ends. 

Comp. Clinic: Comprehensive care clinic, an annual or semi-annual appointment where you will see the doctor, nurse, social worker, physical therapist, and education consultant. 

Cryoprecipitate: Prepared from plasma and contains fibrinogen, von Willebrand factor, factor VIII, factor XIII, and fibronectin. 

Diluent: Saline used to dissolve the concentrated factor powder prior to infusions.

Factor: A product of concentrated clotting protein that the patient is missing, given intravenously.

FLO (Flowing Lightly Onward) Program: A CHKD program that coordinates hematology and gynecology care for heavy or prolonged menstrual bleeding, providing shared assessment and integrated treatment in a single, comprehensive visit.

FMLA (Family Medical Leave Act): Entitles eligible employees of covered employers to take unpaid, job-protected leave for specified family and medical reasons with continuation of group health insurance coverage under the same terms and conditions. 

Fresh frozen plasma: Blood product made from the liquid portion of whole blood. 

Half-life: The time taken for the activity level of infused factor to drop by one half. 

Hormonal therapy: Can be taken to reduce heavy menstrual bleeding. The hormones can increase the levels of VWF and factor VIII in the blood. Can also act as a contraceptive, but not all do.

HTC: Hemophilia and Thrombosis Center.

Infusion: The process of giving the factor replacement product into a vein. 

Inhibitor: An antibody developed that prevents factor replacement treatment from working. 

Non-factor replacement therapy: Therapy that gives rise to a very stable hemostatic level but does not change the factor level.

Peripheral or IV: Access for lab draws and infusions, typically in the arm or hand. 

Pharmacy Benefit Manager (PBM): Health plans and sponsors contract with pharmacy benefits managers to handle the claims processing and administrative functions involved with prescription drug programs.  

PK Study: Pharmacokinetic studies is the study of bodily absorption, distribution, metabolism, and elimination of drugs. Helps determine half-life.

Plasma-derived factor concentrates: Manufacturers take the clotting factors out of plasma from blood donors and freeze-dry it into powder.  Several methods are used to get rid of viruses and unwanted proteins in factor made from plasma. 

Port: A type of central venous access device surgically implanted under the skin to allow easy access to a vein for factor infusion. 

P.R.I.C.E.: Protect, Rest, Ice, Compression, Elevation.

PRN: As needed or on-demand treatment after bleed has occurred.  

Prolonged half-life products or extended half-life: Factor level remains at higher levels for longer periods.

Prophylaxis: Preventative treatment of missing factor protein to prevent bleeds.

Recombinant factor concentrates: In a lab, certain animal cells are turned into factories to make human clotting factor proteins.  It does not come from human blood, so it does not contain viruses or unwanted proteins.

Red Chip Enterprises: Contract specialty pharmacy of the Children’s Hospital of The King’s Daughters hemophilia 340B program.

Specialty Pharmacy Provider: A pharmacy that is designated to provide specialized medications for complex, genetic, rare, and chronic health conditions. Specialty pharmacy providers may provide home health or nursing services. 

Standard half-life or traditional half-life products: Traditional factor products with shorter half-life.

Subcutaneous (SubQ): Into the fatty layer just under the skin.

Trough: The lowest factor level before the next dose is administered.

u/kg: How factor is dosed, units per kilogram.

Venipuncture: Insertion of a needle into a vein, typically with a butterfly needle. 

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.